Prosecution Insights
Last updated: April 19, 2026

Examiner: CLOW, LORI A

Tech Center 3700 • Art Units: 1631 1671 1687 3781

This examiner grants 64% of resolved cases

Performance Statistics

64.0%
Allow Rate
-6.0% vs TC avg
734
Total Applications
+28.7%
Interview Lift
1538
Avg Prosecution Days
Based on 700 resolved cases, 2023–2026

Rejection Statute Breakdown

29.9%
§101 Eligibility
12.5%
§102 Novelty
23.6%
§103 Obviousness
23.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19342186 MODEL-IN-THE-LOOP SYNTHETIC BIOLOGY Final Rejection X Development LLC
17574915 DISEASE REPRESENTATION AND CLASSIFICATION WITH MACHINE LEARNING Non-Final OA X Development LLC
17817631 BIOLOGICAL SEQUENCE DISTANCE EXPLORER SYSTEM PROVIDING USER VISUALIZATION OF GENOMIC DISTANCE BETWEEN A SET OF GENOMES IN A DYNAMIC ZOOMABLE FASHION Non-Final OA International Business Machines Corporation
17371850 IN VITRO EVALUATION METHOD FOR RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH SMOKING OR INHALATION Final Rejection Japan Tobacco Inc.
17761628 METHODS AND SYSTEMS FOR MODELING A CARDIAC SYSTEM Non-Final OA KONINKLIJKE PHILIPS N.V.
17553394 PREDICTING CORE PHENOTYPING DOMAINS OF LOW BACK PAIN WITH MULTIMODAL BRAIN IMAGING METRICS Non-Final OA Washington University
17623818 MULTIPLE BONE DENSITY DISPLAYING METHOD FOR ESTABLISHING IMPLANT PROCEDURE PLAN, AND IMAGE PROCESSING DEVICE THEREFOR Non-Final OA Osstem Implant Co., Ltd.
17655746 SYSTEMS AND METHODS FOR PROCESSING IMAGES TO DETERMINE PLAQUE PROGRESSION AND REGRESSION Non-Final OA HeartFlow, Inc.
17686953 Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity Non-Final OA Laboratory Corporation of America Holdings
18675714 ADAPTING ARRAY LAYOUTS TO ACCOUNT FOR TUMOR PROGRESSION Final Rejection Novocure GmbH
17691999 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID Non-Final OA SEQUENOM, INC.
17730402 PHYSIOLOGICAL IMAGERY GENERATOR SYSTEM AND METHOD Non-Final OA Humana Inc.
17610863 SYSTEMS AND METHODS FOR PHENOTYPING Non-Final OA Technion Research and Development Foundation Limited
17110101 MACHINE LEARNING USING SIMULATED CARDIOGRAMS Final Rejection Vektor Medical, Inc.
17855010 METHOD AND SYSTEM FOR CONVERTING PHYSIOLOGICAL SIGNALS Final Rejection Terra Quantum AG
17190026 Machine Learning Systems and Methods for Predicting Risk of Renal Function Decline Final Rejection pulseData Inc.
18303908 METHOD AND APPARATUS FOR ESTIMATING MENSTRUAL FLUID QUANTITY Non-Final OA Joii Ltd
17290657 METHOD FOR RECORDING ELAPSED TIME IN DNA OF CELLS Final Rejection Yonsei University BioHealth Technology Holdings, Inc.
17745820 Predicting Response to Stimulus Non-Final OA Optios, Inc.
17663427 METHOD AND SYSTEM FOR DETERMINING A RISK OF HEMODYNAMIC COMPROMISE AFTER CARDIAC INTERVENTION Non-Final OA FEops NV
17581809 SYSTEM AND METHOD OF CALIBRATING CEREBRAL SENSOR ORIENTATION AND GENERATING FEEDBACK FROM CEREBRAL SENSOR INJECTOR Non-Final OA Neurasignal, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month